Integrating real-world data in cost-effectiveness analysis of universal HLA-B*15:02 screening in Malaysia.

Huey Yi ChongKheng-Seang LimSi-Lei FongFatiha Hana ShabaruddinMaznah DahluiPauline Siew Mei LaiChing-Ching NgNathorn Chaiyakunapruk

Published in: British journal of clinical pharmacology (2023)

Our study suggests that universal HLA-B*15:02 screening is a cost-effective intervention in Malaysia. With the demonstrated value of real-world evidence in economic evaluations, more relevant standardization efforts should be emphasized to better inform decision-making.

Keyphrases

decision making
randomized controlled trial
electronic health record
machine learning
big data
quality improvement
deep learning
artificial intelligence